Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Results 1 - 20 of 231 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar dfm36410 (< 20) Submitted: 12/29/2015 12:01:53 PM : Outperform Start Price: $69.50 BMY Score: -5.04

Reliable .

Recs

0
Member Avatar steelers50 (27.48) Submitted: 12/24/2015 10:26:07 AM : Outperform Start Price: $67.54 BMY Score: -5.51

Best Pharm Co in the business

Recs

0
Member Avatar Bags (< 20) Submitted: 11/21/2015 10:04:39 PM : Outperform Start Price: $67.45 BMY Score: -1.36

Their product pipeline looks exciting, particularly in oncology. Also, they pay an excellent dividend, with good growth history.

Recs

0
Member Avatar regotoguy (99.61) Submitted: 11/4/2015 6:00:38 PM : Underperform Start Price: $65.43 BMY Score: -1.82

Call me crazy but it would need to drop to $30 to be fairly valued.

Recs

0
Member Avatar KushalJ2w (< 20) Submitted: 10/6/2015 11:07:05 AM : Outperform Start Price: $59.39 BMY Score: +5.52

Consistent performance
Highly focused on R&D
Expanding footprints to other geographies

Recs

0
Member Avatar jobronze (26.81) Submitted: 7/16/2015 12:42:20 AM : Outperform Start Price: $67.19 BMY Score: -0.51

Defensive, best pick in large cap Pharma. Decent yield, incredible pipeline and new found growth focus as bio specialty

Recs

0
Member Avatar SapphireSeas (66.24) Submitted: 6/1/2015 2:29:55 PM : Outperform Start Price: $65.54 BMY Score: +2.41

A leader in cardiovascular R&D and treatments, and now coming on strong with two immunotherapy candidates - ipilimumab and nivolumab - which show tremendous promise.

Recs

0
Member Avatar andrewtraylor (36.16) Submitted: 5/8/2015 6:39:40 PM : Outperform Start Price: $65.85 BMY Score: +1.72

M.I.T.B.- Money in the Bank

Recs

0
Member Avatar hutchcraft2 (56.60) Submitted: 3/18/2015 4:32:47 PM : Outperform Start Price: $66.82 BMY Score: -0.28

Well managed with strong product line.

Recs

0
Member Avatar foolmelgoner (65.74) Submitted: 12/15/2014 8:49:32 PM : Outperform Start Price: $56.62 BMY Score: +10.66

Solid pipeline, good management

Recs

0
Member Avatar AnsgarJohn (96.81) Submitted: 11/16/2014 8:54:06 AM : Underperform Start Price: $56.07 BMY Score: -14.15

Bristol-Myers a favorite of Jima Cramer and Fools, but seems to be getting ahead of itself. PE almost 40, not much growth. End ASAP http://www.gurufocus.com/stock/BMY&summary

Recs

0
Member Avatar JeffRossMD (< 20) Submitted: 10/30/2014 12:44:24 PM : Outperform Start Price: $56.59 BMY Score: +10.89

The biotech space is just heating up as new technologies are revolutionizing cancer and chronic disease processes.

Recs

0
Member Avatar mikeayu (< 20) Submitted: 10/14/2014 7:06:01 PM : Outperform Start Price: $46.97 BMY Score: +25.45

Huge upside from cancel drugs.

Recs

0
Member Avatar afewgoodstocks14 (< 20) Submitted: 10/1/2014 2:23:35 PM : Outperform Start Price: $49.06 BMY Score: +21.73

Div. (Yield) $1.44 (2.8%)

Recs

0
Member Avatar Herbstmd (36.07) Submitted: 8/22/2014 11:55:42 AM : Outperform Start Price: $48.25 BMY Score: +29.27

Developing great new cancer drugs called PD1, which may revolutionize cancer therapy.

Recs

0
Member Avatar hydn (< 20) Submitted: 5/16/2014 10:28:57 AM : Outperform Start Price: $46.70 BMY Score: +27.19

Solid demand for ever improving products.

Recs

0
Member Avatar Johnybe (63.32) Submitted: 5/14/2014 9:46:28 PM : Outperform Start Price: $47.40 BMY Score: +26.19

strong player in this sector

Recs

0
Member Avatar DRGRNR (< 20) Submitted: 4/15/2014 7:52:17 PM : Outperform Start Price: $46.35 BMY Score: +27.30

I've owned BMY for 30 years, always a strong performer.

Recs

0
Member Avatar bassnman45 (53.62) Submitted: 1/2/2014 9:30:25 PM : Outperform Start Price: $20.26 BMY Score: +140.02

buy, hold long term and monitor

Recs

1
Member Avatar johnclanaro (< 20) Submitted: 10/28/2013 3:54:27 PM : Outperform Start Price: $49.23 BMY Score: +14.48

recent upgrade. good pipeline.

Featured Broker Partners